Blueprint Medicines

BPMC

0 Followers

$98.76

-1.04%

-$1.04

7 August

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

BPMC Fair Price

$731.55

Undervalued by 59.4%

To display the fair price of a share, you need to be a member of Bulios Black.

My Notes

Začít psát

Profile

Blueprint Medicines Corporation is a biotechnology company focused on developing precisely targeted therapies for the treatment of rare and oncological diseases. The company focuses on discovering and developing therapeutics that modify specific genetic mutations and molecular pathways associated with various types of cancer and genetic disorders. Blueprint Medicines develops drugs that target specific abnormalities in cells, thereby minimizing side effects and improving treatment efficacy. Its primary areas of research include oncology, hematologic malignancies, and rare genetic diseases.

Feed

There are no posts to show right now.